Unique characteristics of viruses
Mechanism of viral replication inside host cells
Clinical outcomes of viral infections in humans
Major transmission routes of viral diseases
Diagnosis, treatment, and prevention of viral diseases
Emerging viral diseases
Size: Among the smallest infectious agents, ranging from 20 nm (polio) to 400 nm (pox virus).
Non-living: Viruses are not considered living cells as they cannot perform metabolic functions without a host.
Structure:
Nucleic Acid: Single type, either RNA or DNA.
Capsid: Protein coat that encloses the nucleic acid, made up of capsomeres.
Envelope: Some viruses have an outer lipid layer derived from the host cell.
Infection Mechanism: Obligate intracellular parasites relying on host machinery for replication. They damage host cells, causing lysis or gradual death.
Virion: Complete virus particle; can be enveloped (lipid bilayer) or naked (no envelope).
Capsid Functions:
Protects genetic material.
Responsible for attachment and entry into host cells.
Envelope: Contains glycoproteins that assist in binding to host cell receptors.
Based on nucleic acid type, morphology, and replication method. Key classifications include:
DNA Viruses (e.g., Parvoviridae, Adenoviridae)
RNA Viruses (e.g., Picornaviridae, Retroviridae)
Host specificity: Tendency to infect particular species or tissues based on viral attachment sites.
Adsorption: Virus attaches to host cell.
Penetration: Virus enters the cell via various methods.
Uncoating: Viral capsid is removed, releasing nucleic acid.
Synthesis: Host cell enzymes and ribosomes synthesize viral components.
Assembly: New virions are formed from synthesized components.
Release: Viruses exit the host cell by lysis or budding.
Viral infections lead to a variety of symptoms depending on the virus type and host responses. Common diseases include:
Common cold, chickenpox, hepatitis, HIV/AIDS.
Severity and outcomes may vary significantly among individuals.
Immune response includes:
Production of interferon.
Activation of T lymphocytes and B lymphocytes that produce antibodies.
Development of immunity leads to symptoms such as fever and malaise.
Strategies include:
Hiding in host cells.
Mutation of surface proteins to evade immune detection.
Latency where viruses remain dormant then reactivate under stress.
Acute lytic infections: Clear symptoms; full recovery often provides long-lasting immunity.
Subclinical infections: Mild or no symptoms, but may still provoke an immune response.
Persistent infections: Chronic carrier states with ongoing viral replication (e.g., hepatitis B).
Latent infections: Dormant viruses that may reactivate (e.g., herpes).
Oncogenic effects: Some viruses can integrate into host DNA, potentially leading to cancer (e.g., HPV).
Transmission is mainly through body fluids, respiratory droplets, or direct contact. Types include:
Airborne: Virus shed in droplets.
Faecal-oral: Contaminated food/water.
Vector-borne: Insect bites transmitting viruses.
Vertical transmission: From mother to offspring during pregnancy or childbirth.
Reservoirs: Many viruses originate from animal reservoirs (e.g., HIV, Ebola).
Diagnosis often based on clinical symptoms and serological tests for antibodies.
Treatments primarily are symptomatic; antivirals exist but are limited. Understanding viral replication aids in drug development.
Vaccines remain a crucial preventive measure against many viral diseases (e.g., influenza, HPV).
Emerging viral infections continue to be identified, highlighting the need for ongoing research and adaptation of public health measures.
Development of new vaccines and treatments in response to evolving viruses and changing conditions.